{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-005744","form_type":"8-K","ticker":"CPIX","cik":"0001087294","company_name":"CUMBERLAND PHARMACEUTICALS INC","filed_at":"2025-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.899305+00:00","generated_at":"2026-05-26T19:10:53.284558+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Cumberland Pharmaceuticals increases ATM offering size to $10M","bullets":["Maximum aggregate offering price under Sales Agreement with H.C. Wainwright raised to $10,000,000.","Prospectus supplement filed February 14, 2025, amending prior $0 limit or undisclosed prior cap.","Shares of common stock (CPIX) may be sold at-the-market from time to time.","No specific use of proceeds stated in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-005744","json":"https://secwatch.observer/filing/0001628280-25-005744.json","markdown":"https://secwatch.observer/filing/0001628280-25-005744.md","text":"https://secwatch.observer/filing/0001628280-25-005744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025005744/0001628280-25-005744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025005744/cpix-20250214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T19:10:53.284558+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}